![]() |
|
|
Vol. 298, Issue 1, 362-368, July 2001
Departments of Virology (M.T., M.K., Y.F., K.S.) and
Otorhinolaryngology (M.T., Y.W.), Toyama Medical and Pharmaceutical
University, Toyama, Japan; and Division of Pathology (M.I.), National
Cardiovascular Center, Osaka, Japan
The protective role of interleukin (IL)-12 against influenza infection
was assessed by analyzing the efficacies of orally administered
clarithromycin (CAM) as an immunomodulator and intranasal administration of recombinant IL-12 in intranasally influenza virus-infected mice. In infected mice, CAM at 20 mg/mouse/day significantly elevated the levels of IL-12 and interferon-
on days 2 and 3, respectively, after infection in the bronchoalveolar lavage
fluid (BALF), but the levels in the sera were not affected. The
levels of IL-4, -6, and -10 were not significantly affected in the sera
and BALF. Corresponding with the local elevation of IL-12 level, CAM
reduced virus yield and the number of infiltrated cells in the BALF,
the severity of pneumonia, and mortality of the treated mice. The
potential activity of CAM as an experimental immunomodulator was
verified at a dose of 20 mg/mouse/day. Intranasal administration of the
optimal dose (20 ng/mouse) of IL-12 on day 2 significantly reduced
virus yield in the BALF after infection. The loss of body weight was
significantly suppressed by IL-12 administration. The local elevation
of IL-12 level at the optimal dose and timing in influenza infection
was confirmed to be effective in alleviating the influenza infection in
mice treated with the two different ways. Thus, the augmentation of
IL-12 production or administration of supplementary IL-12 in the
respiratory tract was essential in reducing virus yield in the early
phase of influenza and may be crucial for recovery from influenza infection.
This article has been cited by other articles:
![]() |
K. Shin, H. Wakabayashi, K. Yamauchi, S. Teraguchi, Y. Tamura, M. Kurokawa, and K. Shiraki Effects of orally administered bovine lactoferrin and lactoperoxidase on influenza virus infection in mice J. Med. Microbiol., August 1, 2005; 54(8): 717 - 723. [Abstract] [Full Text] [PDF] |
||||